The Food and Drug Administration is proposing a rule that would require doctors to tell women how dense breasts may influence the accuracy of their breast cancer screenings and encourage women with dense breasts to talk to a doctor.
The Food and Drug Administration is proposing a new rule for breast cancer screenings that would require doctors to give women more information about the risks associated with dense breasts, the agency said in a statement Wednesday.
"Given that more than half of women over the age of 40 in the U.S. have dense breasts, helping to ensure patient access to information about the impact that breast density and other factors can have on the risk for developing breast cancer is an important part of a comprehensive breast health strategy," FDA Principal Deputy Commissioner Amy Abernethy said in a statement.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA says cybersecurity vulnerabilities found in some Medtronic devicesThe U.S. Food and Drug Administration (FDA) on Thursday said cybersecurity vulne...
Lire la suite »
Axsome Therapeutics shares soar after FDA grants breakthrough designation to depression drugAxsome Therapeutics Inc. shares jumped 7% in premarket trade Wednesday, after the U.S. Food and Drug Administration granted breakthrough therapy designation...
Lire la suite »
FDA proposes mammography rule to provide women with breast-density informationThe Food and Drug Administration proposes updating of 25-year-old mammography standards to help ensure women get breast density information
Lire la suite »
FDA proposes mammography rule to provide women with information about breast densityThe FDA proposed requiring mammogram providers to notify women with dense breast tissue about how the condition could affect the accuracy of their mammograms and recommend they talk with doctors about whether they should have more tests to check for cancer
Lire la suite »
Women, doctors speak about breast implant illnesses at FDA hearingThe FDA is reviewing the safety of breast implants used by millions of American women at a 2-day hearing about their long-term potential health effects.
Lire la suite »
‘I was not warned’ - Women who say they were sickened by breast implants demand FDA actionAt a hearing, patients, advocates, say the Food and Drug Administration should take steps to warn patients about risks of implants and take some devices off the market.
Lire la suite »
Outgoing FDA chief: Altria bait-and-switched me with $12.8 billion Juul investmentFood and Drug Administration (FDA) Commissioner Scott Gottlieb said on Tuesday that tobacco giant Altria went back on its promise to clamp down on vape pods with its $12.8 billion investment in e-cigarette decacorn Juul Labs.
Lire la suite »
Jazz Pharma's sleep disorder treatment gets FDA nodThe U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc's t...
Lire la suite »
Hackers could take over some implanted defibrillators, FDA saysThe world's largest medical device company has acknowledged that many of its implanted cardiac defibrillators use an unencrypted wireless protocol that could allow an attacker to change the settings of the lifesaving devices.
Lire la suite »
Flood of products containing marijuana extract puts FDA in a bindCBD is blurring the line between a drug and a dietary supplement and testing how much the government can police health claims
Lire la suite »